A Pilot Study of Glutamine PET Imaging of Head and Neck Squamous Cell Carcinoma
Sponsor: M.D. Anderson Cancer Center
Terminated
PI Request
This EARLY_PHASE1 trial investigates Head and Neck Cancer and Head and Neck Squamous Cell Carcinoma and is currently terminated or withdrawn. M.D. Anderson Cancer Center leads this study, which shows 13 recorded versions since 2022 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
13 versions recorded-
May 2025 — Present [monthly]
Terminated EARLY_PHASE1
-
Apr 2025 — May 2025 [monthly]
Terminated EARLY_PHASE1
Status: Active Not Recruiting → Terminated
-
Nov 2024 — Apr 2025 [monthly]
Active Not Recruiting EARLY_PHASE1
-
Sep 2024 — Nov 2024 [monthly]
Active Not Recruiting EARLY_PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting EARLY_PHASE1
▶ Show 8 earlier versions
-
May 2024 — Jul 2024 [monthly]
Active Not Recruiting EARLY_PHASE1
-
Apr 2024 — May 2024 [monthly]
Active Not Recruiting EARLY_PHASE1
Status: Recruiting → Active Not Recruiting
-
Dec 2023 — Apr 2024 [monthly]
Recruiting EARLY_PHASE1
-
Nov 2023 — Dec 2023 [monthly]
Recruiting EARLY_PHASE1
-
Oct 2023 — Nov 2023 [monthly]
Recruiting EARLY_PHASE1
-
Apr 2023 — Oct 2023 [monthly]
Recruiting EARLY_PHASE1
-
Sep 2022 — Apr 2023 [monthly]
Recruiting EARLY_PHASE1
Status: Not Yet Recruiting → Recruiting
-
May 2022 — Sep 2022 [monthly]
Not Yet Recruiting EARLY_PHASE1
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- M.D. Anderson Cancer Center
For direct contact, visit the study record on ClinicalTrials.gov .